Prepared Remarks:

Ryan Weispfenning

Good morning. I am Ryan Weispfenning, vice president and head of Medtronic investor relations. Welcome to Minnesota where signs of spring are in the air. I appreciate that you are joining us today for Medtronic's fiscal 2023 third quarter earnings video webcast.

Before we go inside to hear our prepared remarks, I will share a few details about today's webcast. Joining me are Geoff Martha, Medtronic chairman and chief executive officer; and Karen Parkhill, Medtronic chief financial officer. Geoff and Karen will provide comments on the results of our third quarter, which ended on January 27th, 2023, as well as our outlook for the remainder of the fiscal year. After our prepared remarks, the executive VPs from each of our four segments will join us.

And we will take questions from the sell-side analysts that cover the company. Today's program should last about an hour. Earlier this morning, we issued a press release containing our financial statements and divisional and geographic revenue summaries. We also posted an earnings presentation that provides additional details on our performance.

The presentation can be accessed in our earnings press release or on our website at investorrelations.medtronic.com. During today's program, many of the statements we make maybe considered forward-looking statements and actual results may differ materially from those projected in any forward-looking statement. Additional information concerning factors to cause actual results to differ is contained in our periodic reports and other filings that we make with the SEC and we do not undertake to update any forward-looking statement. Unless we say otherwise, all comparisons are on a year-over-year basis and revenue comparisons are made on an organic basis, which excludes the impact of foreign currency and revenue from our Q1 acquisition of Intersect ENT.

References to sequential revenue changes compared to the second quarter of fiscal '23 and are made on an as-reported basis and all references to share gains or losses refer to revenue share in the fourth calendar quarter of 2022 compared to the fourth calendar quarter of 2021, unless otherwise stated. Reconciliations of all non-GAAP financial measures can be found in our earnings press release or on our website at investorrelations.medtronic.com. And finally, our EPS guidance does not include any charges or gains that would be reported as non-GAAP adjustments to earnings during the fiscal year. With that, let's head into the studio and hear about the quarter.